Covalon Technologies (OTCMKTS:CVALF) Stock Price Down 3% – Should You Sell?

Covalon Technologies Ltd. (OTCMKTS:CVALF)’s share price traded down 3% during trading on Wednesday . The company traded as low as $1.60 and last traded at $1.64. 23,085 shares traded hands during trading, an increase of 1,863% from the average daily volume of 1,176 shares. The stock had previously closed at $1.69.

Covalon Technologies Stock Performance

The company has a fifty day simple moving average of $1.56 and a two-hundred day simple moving average of $1.44. The stock has a market capitalization of $46.23 million, a price-to-earnings ratio of 41.86 and a beta of 0.59.

Covalon Technologies (OTCMKTS:CVALF) last released its earnings results on Thursday, May 21st. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.02. The company had revenue of $6.27 million for the quarter, compared to analyst estimates of $6.70 million. Covalon Technologies had a return on equity of 5.77% and a net margin of 5.05%.

About Covalon Technologies

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.